Evidence map›Paper›PMID 42549451›Full record

ArticleFujita medical journal2026

Stereotactic radiotherapy using a linear accelerator for arteriovenous malformation and arteriovenous fistula identification using 320-row angiography-computed tomography images, case series and a single-center experience.

Fumitaka Ito, Yasunori Saito, Takuro Uchida, Kazuya Takahashi, Kazuhiro Murayama, Sinya Hayashi, Haruka Uezono

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Fujita medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fumitaka ItoDepartment of Radiation Oncology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Yasunori SaitoDivision of Radiology, Fujita Health University Hospital, Toyoake, Aichi, Japan.
Takuro UchidaDepartment of Radiation Oncology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Kazuya TakahashiDepartment of Radiation Oncology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Kazuhiro MurayamaDepartment of Radiology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Sinya HayashiDepartment of Radiation Oncology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Haruka UezonoDepartment of Radiation Oncology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Stereotactic radiotherapy (SRT) and stereotactic radiosurgery (SRS) are useful treatments for arteriovenous malformations (AVMs) and arteriovenous fistulas (AVFs). In this study, 320-row four-dimensional (4D) computed tomography angiography (CTA) was used to determine the irradiation range before SRT/SRS, and the treatment effect was retrospectively evaluated. Methods: Five patients with an AVM and two with an AVF who underwent 4D CTA were included. Treatment was planned and performed based on the 320-row CTA images. Treatment efficacy was evaluated using magnetic resonance imaging and CTA. Results: Shrinkage was observed in four of the five AVMs and both AVFs. Additional irradiation was performed in one AVM patient and one AVF patient. One AVM patient experienced seizures 6 years after treatment. No other adverse neurological events or cerebral hemorrhages occurred. Conclusion: 320-row 4D CTA image fusion was useful for lesion identification in determining radiation treatment plans for AVMs and AVFs. It also was able to demonstrate post-treatment shrinkage and disappearance of lesions.

Indexed as

320-row computed tomography angiographyImage fusionLinear acceleratorStereotactic radiosurgeryStereotactic radiotherapy

Identifiers

PMID42549451
PMCPMC13433068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.